CDK阻害剤CR8は,サイクリンKを枯渇させる分子接着剤として作用する
Mikołaj Słabicki1,2,3, Zuzanna Kozicka4,5, Georg Petzold4
1Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nature
|June 5, 2020
まとめ
研究者は病気を引き起こすタンパク質を 排除する薬である分子分解剤を 発見する新しい方法を発見しました 彼らは,サイクリン依存キナーゼ (CDK) 阻害体であるCR8を,サイクリンKを分解する新しい分子接着剤として特定し,薬剤発見のための新しい戦略を提供した.
科学分野:
- 生物化学
- 薬理学について
- 腫瘍学
背景:
- 分子接着剤は,E3ユビキチンリガース機構を乗っ取ることでタンパク質の分解を誘導する化合物です.
- これらの分解剤は 以前は薬剤で治療できなかったタンパク質を 標的とした有望な治療戦略です
- 分子接着剤の現在の発見方法は,大部分は偶然であり,臨床的応用を制限しています.
研究 の 目的:
- データベース・マイニングを通じて,新しい分子接着剤を体系的に特定する.
- CR8が分子接着剤として機能するメカニズムを調査する
- 既存の阻害剤を分子接着剤に変換するためのより広範な戦略を確立する.
主な方法:
- 癌細胞系におけるE3リガース発現と小分子細胞毒性を相関させる大規模なデータセットの体系的な採掘.
- CR8,CDK12-サイクリンK,DDB1の相互作用を明らかにするための生化学的測定.
- サイクリンKのユビキティレーションとクリアランスを確認するためのタンパク質分解試験
主要な成果:
- 新しい分子粘着分解剤として,サイクリン依存キナーゼ (CDK) 阻害剤であるCR8の特定.
- CR8はCDK12- サイクリンKとDDB1を含む三元複合体を誘導し,基板受容体なしでサイクリンKを分解する.
- 阻害剤の化学的改変が分子接着剤特性を生み出すことが実証された.
結論:
- CR8は新しい分子分解剤で 治療的な応用が可能です
- この研究は,分子接着剤を発見するための体系的なアプローチを示しています.
- 既存の阻害剤を改変することは,新しい分子接着剤を開発するための有効な戦略を提供します.
関連する概念動画
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
00:50Anaphase Promoting Complex
3.3K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
02:39Positive Regulator Molecules
6.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.4K
01:45Positive Regulator Molecules
132.9K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
132.9K
02:15M-Cdk Drives Transition Into Mitosis
6.1K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
02:17Separation of Sister Chromatids
4.2K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.2K